Location History:
- La Jolla, CA (US) (2007 - 2014)
- San Diego, CA (US) (2014)
Company Filing History:
Years Active: 2007-2014
Title: Innovations by Inventor Evan T. Powers
Introduction
Evan T. Powers is an accomplished inventor based in La Jolla, California. With a remarkable portfolio of four patents, he has made significant contributions to the field of therapeutic polypeptides. His work emphasizes innovative approaches to enhancing the stability and functionality of polypeptides, which are crucial in treating various health conditions.
Latest Patents
Among his latest patents is titled "Reliable stabilization of N-linked polypeptide native states with enhanced aromatic sequons located in polypeptide tight turns." This invention details a chimeric therapeutic polypeptide derived from a pre-existing polypeptide. The method focuses on enhancing folded stabilization through a specific amino acid sequence that allows for optimal side-chain interactions. Another significant patent revolves around "Methods for treating transthyretin amyloid diseases," wherein Powers discusses kinetic stabilization of transthyretin as an effective mechanism to prevent protein misfolding. Such misfolding is linked to transthyretin amyloid diseases, and his method outlines effective treatments and prophylaxis methods.
Career Highlights
Evan T. Powers is associated with The Scripps Research Institute, where he conducts pioneering research that influences the development of new therapeutic strategies. His expertise in protein stabilization and polypeptide design has enabled advancements in understanding amyloid diseases.
Collaborations
Throughout his career, Powers has collaborated with notable colleagues such as Jeffery W. Kelly and Hossein Razavi. These partnerships have fostered an environment of innovation and shared knowledge, further propelling research in their respective fields.
Conclusion
Evan T. Powers is a distinguished inventor whose innovative work in the stabilization of polypeptides has greatly impacted therapeutic developments. His patents are critical in advancing treatments for serious diseases, demonstrating his commitment to enhancing healthcare through scientific innovation.